HuGE Literature Finder
Records
1
-
3
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Aug 23 (15): 4035-4045. Jovanovic Bojana, Mayer Ingrid A, Mayer Erica L, Abramson Vandana G, Bardia Aditya, Sanders Melinda E, Kuba M Gabriela, Estrada Monica V, Beeler J Scott, Shaver Timothy M, Johnson Kimberly C, Sanchez Violeta, Rosenbluth Jennifer M, Dillon Patrick M, Forero-Torres Andres, Chang Jenny C, Meszoely Ingrid M, Grau Ana M, Lehmann Brian D, Shyr Yu, Sheng Quanhu, Chen Sheau-Chiann, Arteaga Carlos L, Pietenpol Jennifer |
Copy number variations of E2F1: a new genetic risk factor for testicular cancer. Endocrine-related cancer 2017 Jan . Rocca Maria Santa, Di Nisio Andrea, Marchiori Arianna, Ghezzi Marco, Opocher Giuseppe, Foresta Carlo, Ferlin Alber |
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. Nature communications 2016 Oct 7 13131. Chen Ying-Bei, Xu Jianing, Skanderup Anders Jacobsen, Dong Yiyu, Brannon A Rose, Wang Lu, Won Helen H, Wang Patricia I, Nanjangud Gouri J, Jungbluth Achim A, Li Wei, Ojeda Virginia, Hakimi A Ari, Voss Martin H, Schultz Nikolaus, Motzer Robert J, Russo Paul, Cheng Emily H, Giancotti Filippo G, Lee William, Berger Michael F, Tickoo Satish K, Reuter Victor E, Hsieh James |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: